ZERIA PHARMACEUTICAL CO.,LTD.
TSE Prime
¥1,982.00
+0.00%
Delayed · cached 15 min
Peer comparison
| Company | Price↕ | Market Cap↕ | P/E↕ | P/B↕ | ROE %↕ | ROCE %↕ | Div yield %↕ | Valuation |
|---|---|---|---|---|---|---|---|---|
| CHUGAI PHARMACEUTICAL CO.,LTD. | ¥ 6,422.00 | ¥10兆 5,679億 | 22.42 | 5.21 | 22.10 | 29.80 | 2.15 | Above FV |
| Takeda Pharmaceutical Company Limited | ¥ 5,666.00 | ¥9兆 472億 | -58.56 | 1.18 | -2.10 | 0.05 | 3.54 | — |
| Otsuka Holdings Co.,Ltd. | ¥ 11,335.00 | ¥5兆 9,464億 | 14.75 | 1.84 | 12.60 | 12.04 | 1.48 | Above FV |
| DAIICHI SANKYO COMPANY,LIMITED | ¥ 2,772.00 | ¥5兆 441億 | 19.76 | 2.96 | 15.80 | 7.01 | 2.88 | Above FV |
| Astellas Pharma Inc. | ¥ 2,240.50 | ¥4兆 172億 | 13.81 | 2.07 | 17.40 | 13.43 | 3.50 | Above FV |
| Shionogi & Co.,Ltd. | ¥ 2,827.00 | ¥2兆 4,063億 | 11.72 | 1.36 | 13.50 | 9.85 | 2.51 | Above FV |
| Eisai Co.,Ltd. | ¥ 4,658.00 | ¥1兆 3,147億 | 34.01 | 1.45 | 4.40 | 3.54 | 3.43 | Above FV |
| Kyowa Kirin Co.,Ltd. | ¥ 2,191.50 | ¥1兆 1,474億 | 14.10 | 1.25 | 7.70 | 6.54 | 3.04 | Above FV |
| ONO PHARMACEUTICAL CO.,LTD. | ¥ 2,320.00 | ¥1兆 902億 | 15.63 | 1.26 | 8.50 | 9.43 | 3.41 | Below FV |
| ROHTO PHARMACEUTICAL CO.,LTD. | ¥ 2,788.00 | ¥6,285億 | 19.19 | 2.04 | 12.10 | 11.16 | 1.64 | Above FV |
| Sumitomo Pharma Co.,Ltd. | ¥ 1,527.00 | ¥6,850億 | 5.68 | 1.68 | 46.30 | 15.89 | 0.00 | Below FV |
| SANTEN PHARMACEUTICAL CO.,LTD. | ¥ 1,725.00 | ¥5,550億 | 15.15 | 1.85 | 12.80 | 13.16 | 2.18 | Above FV |
Price, market cap, P/E, P/B and dividend yield reflect the live quote (delayed, cached 15 min); ROE/ROCE from reported financials. The highlighted row is the current company. Click a column header to sort. Educational data only.
How to read the peer comparison
This table places the company beside others in the same industry on a few common measures. Comparison adds context that a single company's numbers cannot give on their own.
- Valuation multiples like P/E and P/B are most meaningful within the same industry, because different industries naturally trade at different levels. Comparing a company only to its peers is more useful than to the whole market.
- Return measures (ROE, ROCE) show how efficiently each company turns capital into profit. A company well ahead of or behind its peers here is worth understanding.
- No single column decides anything. A beginner reads the row across — valuation, returns, and size together — and treats the highlighted current company as one data point among its peers.
- Use the sortable headers to rank peers on any measure, but remember that "cheaper" or "higher" on one metric is a starting question, not an answer.
Educational only — not a recommendation to buy, sell, or hold any security.